You are here

Home » Content

KORONER ANJİYOGRAFİ SONRASI GELİŞEN KOLESTEROL KRİSTAL EMBOLİSİ SENDROMU

CHOLESTEROL CRYSTAL EMBOLIZATION SYNDROME WHICH DEVELOPED AFTER CORONARYANGIOGRAPHY

Journal Name:

  • İstanbul Tıp Fakültesi Dergisi

Publication Year:

  • 2005

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Cholesterol crystal embolization syndrome is a syndrome which is particularly seen in atherosclerotic old patients and may affect multiple organs. There is no specific treatment for this syndrome. Therefore, early diagnosis and prevention are essential. It is highly likely that this syndrome will be seen commonly in the future, because of increasing risky population and invasive procedures. Acase of cholesterol crystal embolization syndrome which was seen in association with commonly used invasive procedures, but not diagnosed at the same rate, was reported.
Bookmark/Search this post with
Abstract (Original Language): 
Kolesterol kristal embolisi sendromu, özellikle aterosklerozu olan yafll› hastalarda görülen ve birçok organ› etkileyebilen bir hastal›kt›r. Özgün bir tedavisi olmamas› nedeniyle, erken tan› ve korunma esast›r. Riskli popülasyonun ve invazif giriflimlerin art›fl› nedeniyle, gelecekte hastal›k ile daha s›k karfl›lafl›lacakt›r. Bu yaz›da, s›kl›¤› geliflen invazif yöntemlere paralel olarak artan, ancak tan›s›- spektrumun genifl olmas› nedeniyle- ayn› oranda artmayan kolesterol embolizasyon sendromu, bir olgu nedeniyle tart›fl›lm›flt›r.
FULL TEXT (PDF): 
PDF icon arastirmax-koroner-anjiyografi-sonrasi-gelisen-kolesterol-kristal-embolisi-sendromu.pdf
  • 2
50-52
  • Turkish

REFERENCES

References: 

KAYNAKLAR
1. Dupont PJ, Lightstone L, Ckutterbuck EJ, Gaskin G. Lesson of the
week: Cholesterol emboli syndrome. BMJ 2000; 321: 1065-1067.
2. Hasegawa M, Kawashima S, Shikano M, Hasegawa H, Tomita
M, Murakami K, Kushimoto H, Katsumata H, Toba T, Oohashi
A, Hiramitsu S, Matsunaga K. The evaluation of corticosteroid
therapy in conjuction with plasma exchange in the treatment of
renal cholesterol embolic disease. A report of 5 cases. Am J
Nephrol 2000; 20: 263-267.
3. Kafl›kç›o¤lu HA, Çam N. Kolesterol Embolizasyon Sendromu:
S›kl›¤› artan ancak tan› oran› artmayan bir sendrom. Türk Kardiyol
Dern Arfl 2002; 30: 647-651.
4. Mann SJ, Sos TA. Treatment of atheroembolization with corticosteroids.
Am J Hypertens 2001; 14: 831-834.
5. Rhodes JM. Cholesterol crystal embolism : an important "new"
diagnosis for the general physician. Lancet 1996; 347: 1641-
1646.
6. Scolari F, Bracchi M, Valzorio B, Movilli E, Costantino E, Savoldi
S, Zorat S, Bonardelli S, Tardanico R, Maiorca R. Cholesterol
atheromatous embolism: an increasingly recognized cause
of acute renal failure. Nephrol Dial Transplant 1996; 11: 1607-
1612.
7. Scolari F, Tardanico R, Pola A, Mazzucchelli C, Maffeis R, Bonardelli
S, Maiorca P, Movilli E, Sandrini S. Cholesterol crystal
embolic disease in renal allografts. J Nephrol 2003; 16: 139-143.
8. Scolari F, Tardanico R, Zani R, Pola A, Viola BF, Movilli E, Maiorca
R. Cholesterol crystal embolism: A recognizable cause of
renal disease. Am J Kidney Dis 2000; 36: 1089-1109.
9. Smith MC, Ghose MK, Henry AR. The clinical spectrum of renal
cholesterol embolization. Am J Med 1981; 71:174-180.
10. Theriault J, Agharazzi M, Dumont M, Pichette V, Ouimet D,
Leblanc M. Atheroembolic renal failure requiring dialysis: potential
for renal recovery, A review of 43 cases. Nephron Clin
Pract. 2003; 94: 11-18.
11. Woolfson RG, Lachmann H. Improvement in renal cholesterol
emboli syndrome after simvastatin. Lancet 1998; 2: 1331-1332.
12. Zuccala A, Zucceli P. Arenal disease frequently found at postmortem,
but rarely diagnosed in vivo. Nephrol Dial Transplant
1997; 12: 1762-1767.

Thank you for copying data from http://www.arastirmax.com